214 related articles for article (PubMed ID: 32107855)
1. Metabolic effects of bezafibrate in mitochondrial disease.
Steele H; Gomez-Duran A; Pyle A; Hopton S; Newman J; Stefanetti RJ; Charman SJ; Parikh JD; He L; Viscomi C; Jakovljevic DG; Hollingsworth KG; Robinson AJ; Taylor RW; Bottolo L; Horvath R; Chinnery PF
EMBO Mol Med; 2020 Mar; 12(3):e11589. PubMed ID: 32107855
[TBL] [Abstract][Full Text] [Related]
2. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice.
Yatsuga S; Suomalainen A
Hum Mol Genet; 2012 Feb; 21(3):526-35. PubMed ID: 22012983
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.
Djouadi F; Habarou F; Le Bachelier C; Ferdinandusse S; Schlemmer D; Benoist JF; Boutron A; Andresen BS; Visser G; de Lonlay P; Olpin S; Fukao T; Yamaguchi S; Strauss AW; Wanders RJ; Bastin J
J Inherit Metab Dis; 2016 Jan; 39(1):47-58. PubMed ID: 26109258
[TBL] [Abstract][Full Text] [Related]
5. The effect of small molecules on nuclear-encoded translation diseases.
Soiferman D; Ayalon O; Weissman S; Saada A
Biochimie; 2014 May; 100():184-91. PubMed ID: 24012549
[TBL] [Abstract][Full Text] [Related]
6. Bezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
Lund M; Andersen KG; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166100. PubMed ID: 33549744
[TBL] [Abstract][Full Text] [Related]
7. Bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells.
Augustyniak J; Lenart J; Gaj P; Kolanowska M; Jazdzewski K; Stepien PP; Buzanska L
Mol Neurobiol; 2019 Jun; 56(6):4346-4363. PubMed ID: 30315479
[TBL] [Abstract][Full Text] [Related]
8. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.
Wenz T; Diaz F; Spiegelman BM; Moraes CT
Cell Metab; 2008 Sep; 8(3):249-56. PubMed ID: 18762025
[TBL] [Abstract][Full Text] [Related]
9. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.
Cabrero A ; Alegret M; Sánchez RM; Adzet T; Laguna JC; Vázquez M
Diabetes; 2001 Aug; 50(8):1883-90. PubMed ID: 11473052
[TBL] [Abstract][Full Text] [Related]
10. Bezafibrate induced increase in mitochondrial electron transport chain complex IV activity in human astrocytoma cells: Implications for mitochondrial cytopathies and neurodegenerative diseases.
Ioannou N; Hargreaves IP; Allen G; Duberley K; Land JM; Heales SJ
Biofactors; 2010; 36(6):468-73. PubMed ID: 20872762
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence that bezafibrate prevents oxidative stress and mitochondrial dysfunction caused by 3-methylglutaric acid in rat liver.
da Rosa-Junior NT; Parmeggiani B; Glänzel NM; de Moura Alvorcem L; Frusciante MR; Dutra Filho CS; Wajner M; Leipnitz G
Biochimie; 2020; 171-172():187-196. PubMed ID: 32169667
[TBL] [Abstract][Full Text] [Related]
12. A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations.
Wenz T; Wang X; Marini M; Moraes CT
J Cell Mol Med; 2011 Nov; 15(11):2317-25. PubMed ID: 21129152
[TBL] [Abstract][Full Text] [Related]
13. Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.
Komen JC; Thorburn DR
Br J Pharmacol; 2014 Apr; 171(8):1818-36. PubMed ID: 24102298
[TBL] [Abstract][Full Text] [Related]
14. Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells.
Douiev L; Sheffer R; Horvath G; Saada A
Cells; 2020 Jan; 9(2):. PubMed ID: 32012656
[TBL] [Abstract][Full Text] [Related]
15. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
16. Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum-Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate.
Seminotti B; Brondani M; Ribeiro RT; Leipnitz G; Wajner M
Mol Neurobiol; 2022 Aug; 59(8):4839-4853. PubMed ID: 35639256
[TBL] [Abstract][Full Text] [Related]
17. Bezafibrate In Vivo Administration Prevents 3-Methylglutaric Acid-Induced Impairment of Redox Status, Mitochondrial Biogenesis, and Neural Injury in Brain of Developing Rats.
da Rosa-Junior NT; Parmeggiani B; da Rosa MS; Glänzel NM; de Moura Alvorcem L; Wajner M; Leipnitz G
Neurotox Res; 2019 May; 35(4):809-822. PubMed ID: 30850947
[TBL] [Abstract][Full Text] [Related]
18. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
[TBL] [Abstract][Full Text] [Related]
19. Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.
Dillon LM; Hida A; Garcia S; Prolla TA; Moraes CT
PLoS One; 2012; 7(9):e44335. PubMed ID: 22962610
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.
Johri A; Calingasan NY; Hennessey TM; Sharma A; Yang L; Wille E; Chandra A; Beal MF
Hum Mol Genet; 2012 Mar; 21(5):1124-37. PubMed ID: 22095692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
